Abstract: According to an aspect, there is provided an apparatus comprising a processor. The processor is configured to receive an image of at least the face of a person whose identity is to be remembered; receive a name of the person whose identity is to be remembered; extract an image feature corresponding to a facial landmark feature from the facial image; select, from a group of images, an image associated with the image feature; determine a name feature from the name, the name feature comprising one or more of: the whole name, part of the name, a homophone of the name or part of the name, a word that rhymes with the name or part of the name, and an anagram of the name or part of the name; associate the name feature with the selected image; and provide the selected image, the name feature, the image of the person whose identity is to be remembered, and the name of the person whose identity is to be remembered for presentation to a patient suffering from cognitive decline or impairment.

Abstract: There is provided a method and apparatus for adjusting a monitoring system which is arranged to receive measured values of a physiological characteristic of a subject and to generate an alarm when the received measured values meet at least one predefined alarm generation criterion.

Abstract: There is provided a method and apparatus for adjusting a monitoring system which is arranged to receive measured values of a physiological characteristic of a subject and to generate an alarm when the received measured values meet at least one predefined alarm generation criterion.

Abstract: There is provided a method for use in monitoring a physiological characteristic of a subject, the method comprising: obtaining a general variability measure of the physiological characteristic, wherein the general variability measure is based on a historical data set of values of the physiological characteristic from a plurality of further subjects; calculating a personalization factor specific to the subject, based on physiological data relating to the subject; generating at least one personalized abnormality criterion for the physiological characteristic, based on the obtained general variability measure and the calculated personalization factor; receiving a measured value of the physiological characteristic of the subject; and determining whether the received measured value is abnormal by comparing it to the at least one personalized abnormality criterion, wherein the received measured value is determined to be abnormal if it meets the at least one personalized abnormality criterion.

Abstract: Various embodiments relate to a system and method for monitoring the heart rate of a user. In particular various embodiments relate to a system comprising an input unit, a time measurement unit, a heart rate sensor, a processing unit and an output unit. The processing unit determines at least one of three different time periods, the first below, the second inside and the third above a single heart rate range defined by the user.

Abstract: An electronically and remotely controlled pill (500) or medicament delivery system is provided. The pill (500) includes a housing (102); a medicament reservoir (104) for storing a medicament; an electronically controlled release valve or hatch (106) for dispensing one or more medicaments stored in the medicament reservoir (104) while traversing the gastrointestinal tract; control and timing circuitry (108) for opening and closing the valve (106); and a battery (109). The control and timing circuitry (108) opens an closes the valve (106) throughout a dispensing time period in accordance with a preset dispensing timing pattern which is programmed within the control and timing circuitry (108). RF communication circuitry receives control signals for remotely overriding the preset dispensing timing pattern, reprogramming the control and timing circuitry (108) or terminating the dispensing of the medicament within the body.

Abstract: The invention relates to a method of determining in vitro the amount of nuclear DNA within a human or animal cell using UV absorption measurement with UV light. The invention also relates to a method for detecting in vitro cancerous cells in a biological sample relying on the aforementioned principles. The invention also relates to an in vitro method of diagnosing or predicting the likely occurrence of cancer in a human or animal subject.

Abstract: An electronically and remotely controlled pill (500) or medicament delivery system is provided. The pill (500) includes a housing (102); a medicament reservoir (104) for storing a medicament; an electronically controlled release valve or hatch (106) for dispensing one or more medicaments stored in the medicament reservoir (104) while traversing the gastrointestinal tract; control and timing circuitry (108) for opening and closing the valve (106); and a battery (109). The control and timing circuitry (108) opens an closes the valve (106) throughout a dispensing time period in accordance with a preset dispensing timing pattern which is programmed within the control and timing circuitry (108). RF communication circuitry receives control signals for remotely overriding the preset dispensing timing pattern, reprogramming the control and timing circuitry (108) or terminating the dispensing of the medicament within the body.

Abstract: An electronically and remotely controlled pill (500) or medicament delivery system is provided. The pill (500) includes a housing (102); a medicament reservoir (104) for storing a medicament; an electronically controlled release valve or hatch (106) for dispensing one or more medicaments stored in the medicament reservoir (104) while traversing the gastrointestinal tract; control and timing circuitry (108) for opening and closing the valve (106); and a battery (109). The control and timing circuitry (108) opens and closes the valve (106) throughout a dispensing time period in accordance with a preset dispensing timing pattern which is programmed within the control and timing circuitry (108). RF communication circuitry receives control signals for remotely overriding the preset dispensing timing pattern, reprogramming the control and timing circuitry (108), or terminating the dispensing of the medicament within the body.

Abstract: The invention proposes a method of detecting respiratory information of a user. The method comprises a step of instructing the user to perform on a device a movement reflecting his respiratory action; a step of generating by said device, a signal reflecting said movement; and a step of deriving the user's respiratory information from said signal. By using this method, the respiratory information is easily detected without attaching any sensor on the user's chest.

Abstract: The invention also relates to an optical sensor for a photoplethysmography measurement, comprising a light unit 1 with a light emitter 2 for emitting light into tissue of a patient 8 and/or a light detector 3 for detecting a part of the emitted light after interaction with the tissue, wherein the light unit is embedded in an elastic material 4. The invention further relates to a device for contactless respiration monitoring of a patient 8, comprising: a distance sensor for consecutively detecting the temporal distance variations relative to the patient's chest 12, preferably based on electromagnetic waves; and a calculating unit for determining the breathing activity based on the detected temporal distance variations. The invention is especially useful for providing a reliable and easy to use possibility for simultaneously monitoring respiration action, blood pressure and heart rate with a handheld device which can be used for spot-checking the vital parameters of patients in hospitals.

Abstract: The invention relates to a method of determining in vivo in a human or animal subject the amount of nuclear DNA by first localizing cell nuclei of living tissue and subsequently measuring the nuclear UV absorbance using confocal scanning microscopy. The invention relates also to a method for detecting cancerous cells in vivo in a human or animal subject by first identifying the localization of cell nuclei in living tissue and subsequently determining the nuclear UV absorbance by laser scanning confocal microscopy. Furthermore, the invention relates to a method of diagnosing cancer in a human or animal subject in vivo relying on a combination of identifying the localization of cell nuclei in living tissue and measuring nuclear UV absorbance by laser scanning confocal microscopy.

Abstract: A patient presses a finger concurrently against a needle (14) of a collection container (12) and a fingerprint surface (22, 52). In one embodiment, the patient's fingerprint is read electronically by a scanner (24) and correlated with a container serial number (16). In another embodiment, the patient's fingerprint is embossed in a foil layer (52). An analyzer assembly (40, 40? 40?) analyzes the biological sample and reads either the container serial number or scans the fingerprint carrying layer (52) and sends the test results and either the fingerprint or container identification to a patient memory (30). Using the fingerprint information, a processor (32) correlates the test results with a record (60) of a corresponding patient. Alternately or additionally, the analyzer assembly includes a DNA analyzer (70) which measures preselected DNA characteristics (76) of the sample.

Abstract: The invention relates to a method of determining in vitro the amount of nuclear DNA within a human or animal cell using UV absorption measurement with UV light. The invention also relates to a method for detecting in vitro cancerous cells in a biological sample relying on the aforementioned principles. The invention also relates to an in vitro method of diagnosing or predicting the likely occurrence of cancer in a human or animal subject.

Abstract: A medical device (1) is in the form of a flexible tube (1) having a first end (2) and a second end (3) each adapted for insertion at separate points through the skin (4) of a body into a blood vessel (5), such that the tube (1) defines a conduit that traverses at least in part above the skin (4) of the body. In use, blood flow is diverted from the body through the tube (1) and back to the body. The fluid flowing through the tube (1) above the skin is available for continuous analysis, for example, by a Raman spectroscopy system (10) that analyses the blood for glucose concentration.

Abstract: An electronically and remotely controlled pill (500) or medicament delivery system is provided. The pill (500) includes a housing (102); a medicament reservoir (104) for storing a medicament; an electronically controlled release valve or hatch (106) for dispensing one or more medicaments stored in the medicament reservoir (104) while traversing the gastrointestinal tract; control and timing circuitry (108) for opening and closing the valve (106); and a battery (109). The control and timing circuitry (108) opens and closes the valve (106) throughout a dispensing time period in accordance with a preset dispensing timing pattern which is programmed within the control and timing circuitry (108). RF communication circuitry receives control signals for remotely overriding the preset dispensing timing pattern, reprogramming the control and timing circuitry (108), or terminating the dispensing of the medicament within the body.

Abstract: The invention relates to a display device for rendering gray tone images on a monitor (31) controlled by s electron rays, wherein a correction unit (33) is provided for generating s output image signals As, which comprise gray tone values forming part of a set K of correction gray tones, from an image signal (34) which comprises gray tone values forming part of a set M of original gray tones (23), and the s output image signals As, after a D/A conversion, are fed each to one electron ray for a brightness-corrected rendering of a gray tone in one pixel of the monitor (31) for the purpose of adapting the brightness distribution of the monitor to the optimum perceptional brightness distribution.

Abstract: The invention relates to a display device for rendering gray tone images on a monitor (31) controlled by s electron rays, wherein a correction unit (33) is provided for generating s output image signals As, which comprise gray tone values forming part of a set K of correction gray tones, from an image signal (34) which comprises gray tone values forming part of a set M of original gray tones (23), and the s output image signals As, after a D/A conversion, are fed each to one electron ray for a brightness-corrected rendering of a gray tone in one pixel of the monitor (31) for the purpose of adapting the brightness distribution of the monitor to the optimum perceptional brightness distribution.

Abstract: The invention relates to a display device for rendering gray tone images on a monitor controlled by s electron rays. The display device includes a correction unit for generating s output image signals As composed of gray tone values forming part of a set K of correction gray tones from an image signal. The image signal is composed of gray tone values forming part of a set M of original gray tones, and the s output image signals As, after a D/A conversion, are fed each to one electron ray for a brightness-corrected rendering of a gray tone in one pixel of the monitor for the purpose of adapting the brightness distribution of the monitor to the optimum perceptional brightness distribution.

Abstract: The invention relates to an AC plasma display panel (12) of the surface discharge type, and more specifically to the structure of the address electrodes (5) of said panel, and to a method of driving said panel. According to the invention, only one address electrode (5) is used for one out of every two columns. Scan (8) and common (7) electrodes may comprise transparent parts (11). These parts (11) may extend over one out every two cells, in a checkerboard fashion. In a preferred embodiment as shown in FIG. 7, the columns may have alternating wide (15) and narrow (16) cells (2). In the driving method according to the invention, all rows are addressed during an addressing phase, and subsequently all rows are simultaneously sustained during a sustain phase.